HOME >> MEDICINE >> NEWS
Drug Combination Including New "Super Aspirin" Drug Cuts Risk Of Death Or Second,,Heart Attack

DALLAS, June 23 -- In a growing class of blood-thinning drugs to treat heart attack, researchers have found one that seems to have a greater long-term benefit rather than only an immediate effect, according to a study released in today's Circulation: Journal of the American Heart Association.

The drug, lamifiban, is in a class of drugs called "platelet IIb/ IIIa receptor blockers," which prevent platelets from forming blood clots that obstruct blood vessels and cause heart attacks. Through a different mechanism, aspirin has a much weaker effect on platelets.

Lamifiban was used alone in varying doses and in combination with heparin, a blood-thinning agent.

The new drug combination may be used to treat patients who have severe chest pain or have had a non-Q-wave, or limited, heart attack. Standard in-hospital treatment for these individuals involves aspirin and heparin.

The study, co-authored by David J. Moliterno, M.D. is among several that are looking into ways to reduce heart attack survivors' high risk for death or a second heart attack in the first year following the attack, with the most critical period being in the first few weeks.

His study is unique in that it suggests a long-term benefit rather than an immediate effect alone. Even with standard treatment, "There is still room for improvement," says Moliterno, of the department of cardiology at The Cleveland Clinic Foundation, Cleveland, Ohio. The number of deaths and second heart attacks is high even at six months after the initial attack, he says.

The Circulation report, however, indicates that if heart attack patients survive the first 30 days, the chances of surviving past six months or even a year are better if they receive lamifiban compared with standard treatment.

"We don't know specifically how long before each individual patient is stabilized after a heart attack," says Moliterno. "Most deaths and second heart attacks tend to oc
'"/>

Contact: Carole Bullock
caroleb@amhrt.org
214-706-1279
American Heart Association
22-Jun-1998


Page: 1 2

Related medicine news :

1. Combination treatment helps thyroid cancer patients live longer
2. Combination therapy, not medication alone, most effective for treating children with OCD
3. Combination of erection pill and testosterone gel may benefit men who fail treatment with pill alone
4. Combination therapy w/ ACTOS (pioglitazone HCI) shown to improve components of diabetic dyslipidemia
5. Combination PET/CT should be used to determine stage of non-small cell lung cancer
6. Combination of toxin and poison may be novel treatment for leukemia
7. Combination drug therapy could substantially improve symptoms of rheumatoid arthritis
8. Combination therapy does not appear to benefit cardiac patients before heart catheter procedure
9. Combination drug therapy offers hope for malaria treatment
10. Combination therapy significantly delays progression of benign prostatic hyperplasia
11. Combination, order of anti-HIV drugs make a difference in first-time recipients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... , ... The American Board of Family Medicine's (ABFM) Board of Directors has ... succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the ... at the end of 2018. Upon assuming the role of President and CEO on ...
(Date:10/13/2017)... ... 13, 2017 , ... Apple Rehab Shelton Lakes , which specializes in ... the facility as part of a disaster drill on October 3rd. , Apple Rehab ... City Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... services for healthcare compliance program management, will showcase a range of technology and ... for Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical ... Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. ... honor of Morris F. Collen, a pioneer in the field of medical informatics, this ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... MIAMI , Sept. 27, 2017  Commended for their ... recent notable awards. Ranked as number one in the South ... ninth time in Inc. 5000 yearly list, the national specialty ... CEO, Armando Bardisa will soon be honored by ... Set to receive his award ...
(Date:9/25/2017)... AMSTERDAM , Sept. 25, 2017   ... Trial Master File solutions, today—from the IQPC Trial ... Amsterdam , NL)—announced that EastHORN Clinical Services ... its clinical programs and TMF management. EastHORN, a ... Montrium,s eTMF platform to increase transparency to enable ...
Breaking Medicine Technology:
Cached News: